NGS-based preimplantation genetic testing (PGT) facilitates the identification of embryos with euploidy, aneuploidy, and chromosomal mosaicism, thus improving IVF pregnancy outcomes compared with array CGH-based screening.
We have utilized our PicoPLEX whole genome amplification technology along with our patented library prep technology in the new Embgenix PGT-A anueploidy screening kit. The kit's simple protocol dramatically improves time to results and reduces handling errors and background. In addition to complete whole genome amplification and library prep, the kit also includes a proprietary cloud-based analysis software for accurate aneuploidy detection and easy reporting.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2022 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.